StreetAlpha
Health Catalyst, Inc. · SEC Form 4

HCAT Insider Trading

From SEC Form 423 trades in 2 yearsUpdated Nov 20, 2026

Every open market buy and sale of Health Catalyst, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $105K bought and $342K sold.

← HCAT stock page

Insiders are net sellers
Bought, 12 months$105K1 buys · 1 insiders
Sold, 12 months$342K3 sales · 2 insiders
Net−$236Kbought minus sold
Planned sales62%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $201KDecJanFebMarAprMayJunJulAug2026-09: bought $105KSepOct2026-11: sold $141KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when HCAT insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an HCAT officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every HCAT insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 12, 2026Benjamin LandryGeneral CounselSale plan99,478$1.42$141K251,894Nov 13Form 4
Sep 14, 2026Simeon KohlCEOBuy59,000$1.79$105K2,856,385Sep 16Form 4
Dec 5, 2025Benjamin LandryGeneral CounselSale plan27,425$2.64$72K100,000Dec 9Form 4
Dec 4, 2025Julie Larson-GreenDirectorSale47,997$2.67$128K73,573Dec 9Form 4
Sep 5, 2025Benjamin LandryGeneral CounselSale plan6,175$3.35$21K141,812Sep 9Form 4
Jun 5, 2025Benjamin LandryGeneral CounselSale plan6,057$3.94$24K151,125Jun 9Form 4
May 5, 2025Daniel LeSueurCOOSale plan5,209$4.10$21K205,832May 7Form 4
Apr 3, 2025Daniel LeSueurCOOSale plan5,209$4.15$22K211,041Apr 7Form 4
Mar 6, 2025Benjamin LandryGeneral CounselSale plan13,827$4.55$63K160,437Mar 10Form 4
Mar 5, 2025Daniel LeSueurCOOSale plan16,902$4.52$76K216,250Mar 10Form 4
Feb 18, 2025Linda LlewelynChief People OfficerSale plan6,441$5.43$35K85,819Feb 20Form 4
Feb 5, 2025Daniel LeSueurCOOSale plan5,209$5.76$30K86,044Feb 6Form 4
Jan 15, 2025Linda LlewelynChief People OfficerSale plan6,442$5.80$37K92,260Jan 17Form 4
Jan 6, 2025Benjamin LandryGeneral CounselSale plan2,500$7.52$19K72,250Jan 10Form 4
Jan 6, 2025Daniel LeSueurCOOSale plan5,209$7.51$39K91,253Jan 10Form 4
🔒 8 more trades. Create a free account or sign in to see them all.

HCAT insider trading FAQ

Are HCAT insiders buying or selling?

Insiders are net sellers over the last 12 months. 1 insiders bought $105K of HCAT on the open market in 1 trades, and 2 sold $342K in 3 trades, 62% of that under pre-arranged trading plans.

When did an HCAT insider last buy shares?

Simeon Kohl (CEO) bought 59,000 shares for $105K on Sep 14, 2026, reported on Sep 16, 2026.

When did an HCAT insider last sell shares?

Benjamin Landry (General Counsel) sold 99,478 shares for $141K on Nov 12, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice